Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cohen & Steers

66.68
+0.53000.80%
Volume:335.02K
Turnover:22.33M
Market Cap:3.40B
PE:21.20
High:67.08
Open:66.56
Low:66.24
Close:66.15
52wk High:110.67
52wk Low:64.29
Shares:51.00M
Float Shares:27.58M
Volume Ratio:1.24
T/O Rate:1.21%
Dividend:2.42
Dividend Rate:3.63%
EPS(TTM):3.15
EPS(LYR):3.00
ROE:32.55%
ROA:14.88%
PB:6.43
PE(LYR):22.22

Loading ...

Press Release: Dyne Therapeutics Appoints Brian Posner to its Board of Directors

Dow Jones
·
Oct 03

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Oct 03

Cohen & Steers Is Maintained at Underperform by B of A Securities

Dow Jones
·
Oct 03

BofA Adjusts Price Target on Cohen & Steers to $68 From $66, Maintains Underperform Rating

MT Newswires Live
·
Oct 02

Cohen & Steers Inc : Bofa Global Research Raises Price Objective to $68 From $66

THOMSON REUTERS
·
Oct 02

Cohen & Steers price target raised to $68 from $66 at BofA

TIPRANKS
·
Oct 02

Cohen & Steers (CNS) Receives a Rating Update from a Top Analyst

TIPRANKS
·
Oct 02

Reviva to Participate in the 4th Annual Roth Healthcare Opportunities Conference

GlobeNewswire
·
Oct 02

Taysha Gene Therapies Announces FDA Breakthrough Therapy Designation and Provides Positive Regulatory Update on TSHA-102 in Rett Syndrome

GlobeNewswire
·
Oct 02

Anavex Life Sciences Announces Successful Development of Once-Daily Oral Tablet Formulation for the ANAVEX®3-71 Program

GlobeNewswire
·
Oct 02

Anavex Life Sciences Announces Positive Topline Results from Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia

GlobeNewswire
·
Oct 02

Cellectar Biosciences Presented Compelling Data in Oral Session and Panel Discussions at the American Association for Cancer Research Special Conference on Discovery and Innovation in Pediatric Cancer

GlobeNewswire
·
Sep 30

Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of Ganesh Kamath as Head of Market Access

GlobeNewswire
·
Sep 30

Anavex Life Sciences Announces Publication of Oral Blarcamesine Describing a New Class of Clinical Precision Medicine from Phase IIb/III Alzheimer’s Disease Trial

GlobeNewswire
·
Sep 30

Silo Pharma Announces $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

GlobeNewswire
·
Sep 30

Press Release: Cohen & Steers Infrastructure Fund, Inc. (UTF) Notification of Sources of Distribution Under Section 19(a)

Dow Jones
·
Sep 30

Applied Therapeutics Provides Update Following Meeting with FDA

GlobeNewswire
·
Sep 29

Tonix Pharmaceuticals Plans to Initiate Prader-Willi Syndrome Phase 2 Trial of TNX-2900 (Intranasal Potentiated Oxytocin) in 2026

GlobeNewswire
·
Sep 29

Plus Therapeutics Announces National Coverage Agreement with UnitedHealthcare For CNS Cancer Diagnostic Kit

Benzinga
·
Sep 25

Cellectar and Evestia Clinical Announce Partnership to Support Auger-Emitting Radiopharmaceutical Clinical Trial in Triple-Negative Breast Cancer (TNBC)

GlobeNewswire
·
Sep 24